Various financial entities participated in the placement, such as Columbus Zuma, the Galicia Financial Group, Supervielle Group Y Santander Bank.
The stock companies AR Partners, Allaria Ledesma, Mariva, Cohen, Futuros del Sur, Rosario Valores, and Galicia Securities were also involved.
It is worth noting that Rizobacter operates in more than 40 countries and has patented high-impact technologies for microbial seeds and agricultural inputs.
In their product portfolio they have inoculants and bio-conductors for sustainable production, seed therapies for disease control (alternative to chemical products, and adjuvants to optimize the efficiency of agricultural applications.
It also manufactures fertilizers, pest control products and markets all varieties of Bioceres seeds wheat and soybeans.
Through its HB4 program®, the company is providing digital solutions to support growers’ decisions and provide full production traceability.
It should be remembered that in November Bioceres received regulatory approval from the National Technical Commission for Biosafety (CTNBio) of the Ministry of Science, Technology and Innovation of Brazil for its HB4® wheat, a crop that has a technology of tolerance to drought unique worldwide.
This innovation is a 100% Argentine development, the product of the public-private collaboration of more than 18 years between the company and the research group of the Instituto de Agrobiotecnología del Litoral (CONICET-UNL), led by Dr. Raquel Chan.